Rahel Schneider

Quantitative Safety & Epidemiology, Novartis Pharma AG, Basel, Switzerland, Switzerland

Poster(s):

• (SLC-033) Establishing standing cohorts of refractory lupus patients in the fit-for-purpose Real-World Data (RWD) sources to facilitate contextualization of upcoming clinical trial safety data: A feasibility project
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET